Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 4:12 pm Purchase | 2024-09-16 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 605,531 19.900% | 3,531 (+0.59%) | Filing History |
| 2024-10-25 4:24 pm Sale | 2024-10-23 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 1,182,717 4.800% | -941,550 (-44.32%) | Filing History |
| 2024-10-17 4:16 pm Purchase | 2024-10-15 | 13D | Upstream Bio, Inc. UPB | ORBIMED ADVISORS LLC | 4,554,873 8.900% | 4,554,873 (New Position) | Filing History |
| 2024-10-01 5:35 pm Sale | 2024-09-27 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,124,267 8.600% | -313,700 (-12.87%) | Filing History |
| 2024-09-23 6:44 pm Purchase | 2024-09-16 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 602,000 19.900% | 602,000 (New Position) | Filing History |
| 2024-09-23 4:34 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | ORBIMED ADVISORS LLC | 3,812,215 12.000% | 3,812,215 (New Position) | Filing History |
| 2024-09-16 8:29 pm Unchanged | 2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,562,971 9.000% | 0 (Unchanged) | Filing History |
| 2024-09-10 4:12 pm Unchanged | 2024-09-03 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 52.700% | 0 (Unchanged) | Filing History |
| 2024-08-15 4:47 pm Purchase | 2024-08-13 | 13D | scPharmaceuticals Inc. SCPH | ORBIMED ADVISORS LLC | 6,059,528 12.100% | 500,000 (+8.99%) | Filing History |
| 2024-08-15 4:38 pm Sale | 2024-08-13 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 500 0.050% | -85,655 (-99.42%) | Filing History |
| 2024-08-09 4:09 pm Sale | 2024-07-31 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 1,965,266 3.800% | -684,198 (-25.82%) | Filing History |
| 2024-07-18 5:33 pm Sale | 2024-07-16 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,562,971 11.700% | -56,164 (-0.74%) | Filing History |
| 2024-07-02 4:58 pm Sale | 2024-06-28 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,437,967 9.900% | -428,300 (-14.94%) | Filing History |
| 2024-06-20 5:15 pm Purchase | 2024-06-17 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,785,571 6.000% | 83,334 (+4.90%) | Filing History |
| 2024-05-22 7:32 pm Unchanged | 2024-05-20 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 86,155 7.900% | 0 (Unchanged) | Filing History |
| 2024-05-20 4:55 pm Sale | 2024-05-16 | 13D | Enliven Therapeutics, Inc. ELVN | ORBIMED ADVISORS LLC | 7,918,163 16.800% | -1,033,300 (-11.54%) | Filing History |
| 2024-05-08 7:55 pm Unchanged | 2024-05-06 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 11.100% | 0 (Unchanged) | Filing History |
| 2024-04-12 5:35 pm Unchanged | 2024-04-09 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 8,034,000 13.000% | 0 (Unchanged) | Filing History |
| 2024-04-04 4:39 pm Purchase | 2024-04-02 | 13D | Enliven Therapeutics, Inc. ELVN | ORBIMED ADVISORS LLC | 8,951,463 19.200% | 2,124 (+0.02%) | Filing History |
| 2024-03-28 4:28 pm Purchase | 2024-03-26 | 13D | Q32 Bio Inc. QTTB | ORBIMED ADVISORS LLC | 2,252,987 18.900% | 2,252,987 (New Position) | Filing History |